/https://tf-cmsv2-smithsonianmag-media.s3.amazonaws.com/filer_public/8a/d6/8ad64075-57a2-4239-93d4-6baf3489bedd/gettyimages-1793641166.jpg)
Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
combination therapy with glp-1 receptor agonist and sglt2 inhibitor Current Insights, Advantages Challenges of Small Molecule Glucagon-like Peptide 1 Agonists: A Scoping Review GLP-1 Therapeutics and Their Brain & Sleep Type:Paperback
GLP-1 Therapeutics and Their Emerging Role in Alcohol and Substance Use Disorders: An Endocrinology Primer - PMC
doi: 10.3803/EnM.2021.102 Summary Keywords GLP-1 receptor agonists, endocrine, cardiovascular, neurological, cancer Citation Zhao X, Wang M, Wen Z, Lu Z, Cui L, Fu C, Xue H, Liu Y and Zhang Y (2021) GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
Brain & Sleep
Type:Paperback
As a GLP-1 receptor agonist, it mimics the body's own hormone GLP-1 (glucagon-like peptide-1) and selectively binds to the GLP-1 receptor, thereby stimulating the secretion of insulin and lowering blood glucose levels [15]
US$ 20.93
US$ 24.47
US$ 28.39
US$ 27.35
